Welcome to LookChem.com Sign In|Join Free

CAS

  • or
6-bromo-1-phenyl-1H-indazole-3-thiol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1345403-95-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1345403-95-3 Structure
  • Basic information

    1. Product Name: 6-bromo-1-phenyl-1H-indazole-3-thiol
    2. Synonyms: 6-bromo-1-phenyl-1H-indazole-3-thiol
    3. CAS NO:1345403-95-3
    4. Molecular Formula:
    5. Molecular Weight: 305.198
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1345403-95-3.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 6-bromo-1-phenyl-1H-indazole-3-thiol(CAS DataBase Reference)
    10. NIST Chemistry Reference: 6-bromo-1-phenyl-1H-indazole-3-thiol(1345403-95-3)
    11. EPA Substance Registry System: 6-bromo-1-phenyl-1H-indazole-3-thiol(1345403-95-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1345403-95-3(Hazardous Substances Data)

1345403-95-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1345403-95-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,5,4,0 and 3 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1345403-95:
(9*1)+(8*3)+(7*4)+(6*5)+(5*4)+(4*0)+(3*3)+(2*9)+(1*5)=143
143 % 10 = 3
So 1345403-95-3 is a valid CAS Registry Number.

1345403-95-3Relevant articles and documents

INDAZOLE COMPOUNDS USEFUL AS KETOHEXOKINASE INHIBITORS

-

Page/Page column 20, (2011/11/06)

The present invention is directed to substituted indazole compounds, pharmaceutical compositions of these compounds and methods of use thereof. The compounds of the present invention are ketohexokinase (KHK) inhibitors, useful for treating or ameliorating a KHK mediated metabolic disorders and/or diseases such as obesity, Type II diabetes mellitus and Metabolic Syndrome X.

Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors

Zhang, Xuqing,Song, Fengbing,Kuo, Gee-Hong,Xiang, Amy,Gibbs, Alan C.,Abad, Marta C.,Sun, Weimei,Kuo, Lawrence C.,Sui, Zhihua

, p. 4762 - 4767 (2011/09/16)

A series of indazoles have been discovered as KHK inhibitors from a pyrazole hit identified through fragment-based drug discovery (FBDD). The optimization process guided by both X-ray crystallography and solution activity resulted in lead-like compounds with good pharmaceutical properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1345403-95-3